Old Web
English
Sign In
Acemap
>
authorDetail
>
Andrew Goldfine
Andrew Goldfine
Princeton University
Clinical research
Disease
ABL Tyrosine Kinase
Adverse effect
Randomization
1
Papers
3
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (1)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Results of a Phase 1 Dose-Ranging Trial, and Design of a Phase 2 Trial, of K0706, a Novel C-Abl Tyrosine Kinase Inhibitor for Parkinson’s Disease. (P2.8-047)
2019
Neurology
Andrew Goldfine
Robert K. Faulkner
Vasu Sadashivam
Omid Omidvar
John Hill
Singaravelu Jagadeesan
Anil Sharma
Siu-Long Yao
Show All
Source
Cite
Save
Citations (3)
1